Literature DB >> 34705022

Association of Age With the Diagnostic Value of Coronary Artery Calcium Score for Ruling Out Coronary Stenosis in Symptomatic Patients.

Martin Bødtker Mortensen1,2, Sara Gaur1, Attila Frimmer1, Hans Erik Bøtker1, Henrik Toft Sørensen3, Kristian Hay Kragholm4, Sand Rønnow Niels Peter5, Flemming Hald Steffensen6, Rebekka Vibjerg Jensen1, Michael Mæng1, Helle Kanstrup1, Michael J Blaha2, Leslee J Shaw7, Omar Dzaye2, Jonathon Leipsic8, Bjarne Linde Nørgaard1, Jesper Møller Jensen1.   

Abstract

Importance: The diagnostic value is unclear of a 0 coronary artery calcium (CAC) score to rule out obstructive coronary artery disease (CAD) and near-term clinical events across different age groups. Objective: To assess the diagnostic value of a CAC score of 0 for reducing the likelihood of obstructive CAD and to assess the implications of such a CAC score and obstructive CAD across different age groups. Design, Setting, and Participants: This cohort study obtained data from the Western Denmark Heart Registry and had a median follow-up time of 4.3 years. Included patients were aged 18 years or older who underwent computed tomography angiography (CTA) between January 1, 2008, and December 31, 2017, because of symptoms that were suggestive of CAD. Data analysis was performed from April 5 to July 7, 2021. Exposures: Obstructive CAD, which was defined as 50% or more luminal stenosis. Main Outcomes and Measures: Proportion of individuals with obstructive CAD who had a CAC score of 0. Risk-adjusted diagnostic likelihood ratios were used to assess the diagnostic value of a CAC score of 0 for reducing the likelihood of obstructive CAD beyond clinical variables. Risk factors associated with myocardial infarction and death were estimated.
Results: A total of 23 759 symptomatic patients, of whom 12 771 (54%) had a CAC score of 0, were included. This cohort had a median (IQR) age of 58 (49-65) years and was primarily composed of women (13 160 [55%]). Overall, the prevalence of obstructive CAD was relatively low across all age groups, ranging from 3% (39 of 1278 patients) in those who were younger than 40 years to 8% (52 of 619) among those who were 70 years or older. In patients with obstructive CAD, 14% (725 of 5043) had a CAC score of 0, and the prevalence varied across age groups from 58% (39 of 68) among those who were younger than 40 years, 34% (192 of 562) among those aged 40 to 49 years, 18% (268 of 1486) among those aged 50 to 59 years, 9% (174 of 1963) among those aged 60 to 69 years, to 5% (52 of 964) among those who were 70 years or older. The added diagnostic value of a CAC score of 0 decreased at a younger age, with a risk factor-adjusted diagnostic likelihood ratio of a CAC score of 0 ranging from 0.68 (approximately 32% lower likelihood of obstructive CAD than expected) in those who were younger than 40 years to 0.18 (approximately 82% lower likelihood than expected) in those who were 70 years or older. The presence of obstructive vs nonobstructive CAD among those with a CAC score of 0 was associated with a multivariable adjusted hazard ratio of 1.51 (95% CI, 0.98-2.33) for myocardial infarction and all-cause death; however, this hazard ratio varied from 1.80 (95% CI, 1.02-3.19) in those who were younger than 60 years to 1.24 (95% CI, 0.64-2.39) in those who were 60 years or older. Conclusions and Relevance: This cohort study found that the diagnostic value of a CAC score of 0 to rule out obstructive CAD beyond clinical variables was dependent on age, with the added diagnostic value being smaller for younger patients. In symptomatic patients who were younger than 60 years, a sizable proportion of obstructive CAD occurred among those without CAC and was associated with an increased risk of myocardial infarction and all-cause death.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34705022      PMCID: PMC8552116          DOI: 10.1001/jamacardio.2021.4406

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   30.154


  9 in total

1.  One step closer to quantifying 'clinical likelihood' in pre-test probability.

Authors:  Jonathan R Weir-McCall; Michelle C Williams; Angela Wood
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-09-05

Review 2.  Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs.

Authors:  Thomas O'Toole; Michelle D Kelsey; Nishant P Shah; Robert W McGarrah; Neha J Pagidipati
Journal:  Curr Cardiol Rep       Date:  2022-08-25       Impact factor: 3.955

3.  Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline.

Authors:  Rhanderson Cardoso; Leslee J Shaw; Roger S Blumenthal; Khurram Nasir; Richard Ferraro; David J Maron; Michael J Blaha; Martha Gulati; Deepak L Bhatt; Ron Blankstein
Journal:  Am J Prev Cardiol       Date:  2022-06-30

4.  Early Markers of Cardiovascular Disease Associated with Clinical Data and Autosomal Ancestry in Patients with Type 1 Diabetes: A Cross-Sectional Study in an Admixed Brazilian Population.

Authors:  Roberta Maria Duailibe Ferreira Reis; Rossana Santiago de Sousa Azulay; Maria da Glória Tavares; Gilvan Cortês Nascimento; Sabrina da Silva Pereira Damianse; Viviane Chaves de Carvalho Rocha; Ana Gregória Almeida; Débora Cristina Ferreira Lago; Vandilson Rodrigues; Marcelo Magalhães; Carla Souza Sobral; Conceição Parente; Joana França; Jacqueline Ribeiro; Paulo Cézar Dias Ferraz; Carlos Alberto Azulay Junior; Dayse Aparecida Silva; Marília Brito Gomes; Manuel Dos Santos Faria
Journal:  Genes (Basel)       Date:  2022-02-21       Impact factor: 4.096

5.  Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores.

Authors:  Tsung-Ying Tsai; Pai-Feng Hsu; Cheng-Hsueh Wu; Shao-Sung Huang; Wan-Leong Chan; Shing-Jong Lin; Jaw-Wen Chen; Tse-Min Lu; Hsin-Bang Leu
Journal:  Nutrients       Date:  2022-07-30       Impact factor: 6.706

6.  Cardiac Computed Tomography: State of the Art and Future Horizons.

Authors:  Gudrun M Feuchtner; Fabian Plank; Christoph Beyer; Fabian Barbieri; Gerlig Widmann; Philipp Spitaler; Wolfgang Dichtl
Journal:  J Clin Med       Date:  2022-07-29       Impact factor: 4.964

7.  Coronary artery calcification-does it predict the CAD-RADS category?

Authors:  Maryam Moradi; Ebrahim Rafiei; Sina Rasti; Hossein Haghbin
Journal:  Emerg Radiol       Date:  2022-08-04

Review 8.  High-Risk Coronary Plaque Features: A Narrative Review.

Authors:  Luke P Dawson; Jamie Layland
Journal:  Cardiol Ther       Date:  2022-06-22

Review 9.  Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat.

Authors:  Keith M Channon; David E Newby; Edward D Nicol; John Deanfield
Journal:  Heart       Date:  2022-09-12       Impact factor: 7.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.